ASTRA MERCK ROFLEPONIDE ASTHMA STEROID TO FILL MILD/PEDIATRIC ASTHMA NICHE, ASTRA SAYS; PULMICORT/OXIS COMBO TRIALS IN 2,000 PATIENTS "ABOUT TO START"
Executive Summary
Astra's next inhaled steroid project, rofleponide, will be especially useful for children and mild asthmatics, Astra Draco VP-Clinical R&D Anders Ullman suggested during a Jan. 22 meeting with financial analysts in London.